Navigation Links
Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Sarcoma and Osteosarcoma: Phase I/II and Phase II Studies, ASCO 2009
Date:5/18/2009

Katherine Janeway, Dana-Farber Cancer Institute, Boston, MA on Saturday, May 30, 2009 at 5:00 p.m. EST/EDT.

About Epeius Biotechnologies

Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic medicine with the development and commercialization of its high-performance gene delivery systems that are embodied in Rexin-G and Reximmune-C, a tumor-targeted cancer vaccine. To learn more about ongoing clinical trials, please contact Dr. Erlinda M. Gordon at egordon@epeiusbiotech.com.

*(LOGO 72dpi: Send2Press.com/mediaboom/08-0421-Epeius_72dpi.jpg)

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE Epeius Biotechnologies
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A.
2. Lesson From the States: Lack of Cost Controls Derailed California Health Reform, Led to Budget Overruns and Unaffordable Policies in Massachusetts
3. China Shenghuo Announces Management Expansion and Enhanced Internal Controls
4. Enhanced skin cancer risk linked to defects in cellular aging controls
5. Best Practice Database Supports Chemistry, Manufacturing & Controls (CMC) Operations
6. Gems Sensors & Controls Introduces Highly Accurate FDA Compliant Flow Sensor
7. Molecular partnership controls daily rhythms, body metabolism
8. NIH scientists find a novel mechanism that controls the development of autoimmunity
9. Gladstone scientists identify single microRNA that controls blood vessel development
10. MicroRNA controls expression of oncogenes
11. Monkey Controls Robotic Arm With Brain

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...tack recipient,s tissue, study finds, , ... are reporting that a genetic variation -- a missi...a bone-marrow transplant will develop a complicati...une system-related complication occurs after surge...nor does not. , When that,s the case, the immu...
(Date:11/22/2009)...an innovative healthcare benefit solutions company...ed a recapitalization with Silver Point Capital, L... Point Capital, L.P. is a private investment firm ...ation allows the Company to continue its growth an... (PRWEB) November 22, 2009 -- Health...
(Date:11/22/2009)...hine post You Tube video demonstrating the Really ... Landover, MD (PRWEB) November 22, 20...ng what a really rugged waterproof keyboard can wi...ard vs Washable Competitors Keyboard HD” vid...emium, Really Cool Keyboard from Man & Machin...
(Date:11/21/2009)...wire-USNewswire/ -- Tonight, in a partisan vote, t...version of the government takeover of health care.... this bill; like the public option, employer and i...elective abortion, which is the most onerous and m...es subsidies for private plans that cover elective...
(Date:11/21/2009)... an unprecedented expansion of federally-funded ab... preserving and protecting human life? If the bill...Yoest ,, WASHINGTON, Nov. 21 /PRNewswire-USNe...ent and CEO Dr. Charmaine Yoest responded to tonig... statement: ,, "This was a pro-abortion vote t...
Breaking Medicine News(10 mins):Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2
...tment of Veterans Affairs intends to solicit outsi...t two important technical studies that will,assist...r military,disability system. The studies are part...ealth and Human Services,Secretary Donna Shalala.,...
...(Nasdaq: CRDC ) today announced the pricing of an...of its common stock for sale by Cardica and,2,579,...ng stockholder, at,a price to the public of $8.50 ...over-allotments, if any. Cardica will,not receive ...
... Texas, Nov. 9 - then in Chicago, LA and D.C., E...ilitary and vets,since World War I, NEW HAVEN, Co...te a total of $1 million worth of wheelchairs to,v...of the U.S. military., The Knights of Columbus ha...
...ics Europe, BRAINTREE, Mass., Nov. 8 Haemonetics...rdon will join the company,effective November 12, ...n,will have responsibility for European operations... He will also join,Haemonetics, global Operating C...
...stCall/ -- China Sky One,Medical, Inc. (OTC Bullet...ributor of pharmaceutical, medicinal and diagnosti...mpleted the previously announced amendment to,the ...September 30, 2007, management determined that cer...
... RANCHO CORDOVA, Calif., Nov. 8 ThermoGenesis,Co...tive products and,services that process, store, an... for treatment of disease and injury, today report...million for the first quarter of fiscal,2007. Tota...
Other Medicine News:Health News:Modernizing and Improving the Disability and Compensation Systems 2Health News:Modernizing and Improving the Disability and Compensation Systems 3Health News:Cardica Announces Pricing of $34.7 Million Public Offering of Common Stock 2Health News:Cardica Announces Pricing of $34.7 Million Public Offering of Common Stock 3Health News:Knights to Distribute $1 Million Worth of Wheelchairs for Veterans 2Health News:Haemonetics Appoints Executive Leadership of European Operations 2Health News:China Sky One Medical Completes Previously Announced Amendment to 2006 Form 10KSB 2Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 2Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 3Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 4Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 5Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 6Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 7
(Date:11/20/2009)... , NEW YORK, Nov. 20 ,, ...rch report is available in its catalogue. ,, I...ts to 2015 ,, http://www.reportlinker.com/p0...-Forecasts-to-2015.html#utm_source=prnewswire&... Description ,, India Medical Equipment Market...
(Date:11/20/2009)... , NEW YORK, Nov. 20 Reportl...ort is available in its catalogue. ,, Medical ... http://www.reportlinker.com/p0164242/Medical-Ad..._source=prnewswire&utm_medium=pr&utm_campa...s and sealants is gaining preeminence in medical d...
(Date:11/20/2009)... , HOUSTON, Nov. 20 ...that Dan Moore, President and Chief Executive Offi...l present at the 21st Annual Piper Jaffray Health ... 2, 2009 at 12:00 PM EST. The conference session ...s will be presented. Piper Jaffray will host a we...
Breaking Medicine Technology:Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 3Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 4Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 6Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 7Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 9Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 10Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 11Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 12Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 13Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Valeritas Announces Appointment of New CEO 12391 1Valeritas Announces Appointment of New CEO 12391 2Valeritas Announces Appointment of New CEO 12391 3Researchers determine predicting factors of positive lung cancer diagnoses in chest radiographs 47488 117 million US children live more than an hour away from trauma care 47486 117 million US children live more than an hour away from trauma care 47486 2
...IRE)--May 4, 2007 - New data have,demonstrated tha...tients treated with COPAXONE(R) (glatiramer acetat...h mitoxantrone experienced a,90 percent reduction ...ase activity compared to their baseline. These ben...roughout the 24-month study,period. These long-ter...
...2007 - CeNeS Pharmaceuticals plc,(LSE: CEN), the C...e publication of an independent study in the respe... NMDA antagonist, CNS 5161. CeNeS,is developing CN...in. The independent study builds on the work that ...he study reported in ,Synapse, Dr Anat Biegon and...
Other Medicine Technology:Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 2Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 3Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 4Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 5Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 6Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 7Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 2Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 3
Calcitonin RIA Kit
...s the first completely digital camera system by KA...doscopic camera systems. Digital Source Sampling t...tates the fully digital transfer of information wi...ell as loss-free data storage on all known digital...
Erbium Laser with Sapphire Erbium Handpiece for Dermatological and Cosmetic Surgery
imEXPRESS
Medicine Products: